Needham & Company Sees Little Upside in Medivation (MDVN)
Tweet Send to a Friend
Needham & Company analyst Chad Messer weighed in on Hold-rated Medivation (NASDAQ: MDVN), saying another Xtandi miss is being overlooked ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


